OSANG Healthcare Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Private

  • Employees
  • 285

Employees

  • Latest Deal Type
  • M&A
  • (Cancelled)

  • Latest Deal Amount
  • $30.5M

OSANG Healthcare General Information

Description

Developer of diagnostic biosensors for blood glucose measurement intended to create superior value for customers through innovation and differentiating technology. The company's product offering includes a blood glucose monitoring system, HbA1c analyzer, cholesterol measuring system, immune diagnostic device and molecular diagnostic devices.

Contact Information

Website
www.osanghc.com
Formerly Known As
Infopia
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 132, Anyangcheondong-ro
  • Dongan-gu
  • Anyang-si, Gyeonggi-do 431-080
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OSANG Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Apr-2015 $30.5M 000.00 Cancelled Profitable
2. IPO 05-Jun-2007 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view OSANG Healthcare’s complete valuation and funding history, request access »

OSANG Healthcare Patents

  • 179

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 24

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

OSANG Healthcare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4202411-A1 Measurement device with light quantity correction function and light quantity correction method thereof Pending 27-Dec-2021 0000000000 0
US-20230147691-A1 Method of manufacturing coronavirus diagnostic kit, virus diagnostic kit manufactured thereby and method of diagnosing coronavirus using the same Pending 22-Apr-2020 0000000000
EP-4109077-A1 Chromatographic testing device configured to select imaging scheme according to type of fluorescent dye, and method for controlling same Pending 21-Feb-2020 00000000000
US-20230055598-A1 Chromatographic testing device configured to select imaging scheme according to type of fluorescent dye, and method for controlling same Pending 21-Feb-2020 00000000000
EP-4099002-A1 Chromatographic inspection apparatus and control method thereof Pending 30-Jan-2020 G01N21/8483
To view OSANG Healthcare’s complete patent history, request access »

OSANG Healthcare Executive Team (3)

Name Title Board Seat Contact Info
Ko Suk President & Chief Executive Officer
Sung-Dong Lee Managing Director
Byeong-Woo Bae Vice President
To view OSANG Healthcare’s complete executive team members history, request access »

OSANG Healthcare Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OSANG Healthcare Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IMBdx 01-Mar-2019 00000 0000 00.000 Discovery Tools (Healthcare)
To view OSANG Healthcare’s complete investments history, request access »

Ready to get started?

Request a free trial